Related Experiment Videos
Evaluation of fibrosis and hepatitis C
1Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
The American Journal of Medicine
|February 1, 2000
Summary
Hepatitis C fibrosis progression is key to prognosis, with cirrhosis being irreversible. Early detection and noninvasive markers are crucial for managing liver disease, as current methods like liver biopsy are invasive.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Prognosis of hepatitis C is primarily determined by the extent and progression of liver fibrosis.
- Fibrosis, characterized by extracellular matrix accumulation, is reversible, unlike irreversible cirrhosis.
- Extensive fibrosis can be asymptomatic and undetected, highlighting the need for better diagnostic tools.
Purpose of the Study:
- To review the current understanding of hepatitis C fibrosis progression.
- To emphasize the need for noninvasive markers for fibrosis assessment.
- To highlight the importance of host factors in determining fibrosis rate.
Main Methods:
- Review of clinical trial data and existing literature on hepatitis C fibrosis.
- Discussion of the Metavir system as a validated method for fibrosis scoring.
- Exploration of the cellular and molecular mechanisms of fibrosis, including hepatic stellate cell activation.
Main Results:
- Viral factors predict therapy response but not fibrosis rate.
- Host factors like age, gender, and alcohol intake influence fibrosis.
- Hepatic stellate cells are identified as the primary source of extracellular matrix in fibrosis.
Conclusions:
- Liver biopsy remains the gold standard for fibrosis assessment, but noninvasive markers are urgently needed.
- Further research into the cellular basis and natural history of fibrosis is essential.
- Improved understanding will aid in developing better treatments for hepatitis C as therapies advance.